Ruixue Chen

Ruixue Chen

Auto-generated profile, based on publicly available information

Ruixue Chen

School of Chinese Medicine, Jinan University, Guangzhou, Guangdong 510632, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2017 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
JYJing Yuan
Jing Yuan
MCMinghao Chen
Minghao Chen
QXQingyun Xu
Qingyun Xu
JLJianxin Liang
Jianxin Liang
RCRuixue Chen
Ruixue Chen
LCLiguo Chen
Liguo Chen
Background/Aims: This study aimed to screen microRNAs and their corresponding target genes that are associated with vascular injury in type two diabetes mellitus (T2DM), investigate the effects of differentially expressed miRNAs and their target genes on high glucose-induced vascular injury and establish the mechanism underlying these effects. Methods: A high-throughput digital gene expression (DGE) sequencing was performed to sequence microRNAs (miRNAs) and messenger RNAs (mRNAs) and determine their differential expression in human umbilical vein endothelial cells (HUVECs) incubated with serum samples from patients with T2DM and healthy volunteers. The HUVECs were transfected with si-TNF-α (tumor necrosis factor α) and a miR-149-5p inhibitor or mimic in vitro and then treated with normal or high glucose. The relative content of nitric oxide (NO) in the cells was detected using the Griess Reagent System. The mRNA and protein expression of endothelial nitric oxide synthase (eNOS) were determined by qRT-PCR and Western blotting. The content of endothelin-1 (ET-1), von Willebrand factor (vWF), and intercellular adhesion molecular-1 (ICAM-1) were detected using an enzyme-linked immunosorbent assay (ELISA) kit. Apoptosis was determined by flow cytometry using the Annexin V/PI apoptosis detection kit. The mRNA and protein expression levels of ER stress (ERS) markers were determined by qRT-PCR and Western blotting. Results: Based on the high-energy sequencing and in vitro pre-experiment studies, we determined that miR-149-5p and TNF-α were a differentially expressed mRNA/miRNA pair in T2DM with vascular injury. The luciferase reporter assay results demonstrated that miR-149-5p could directly target TNF-α. The upregulation of miR-149-5p reduced the high glucose-induced dysfunction in the HUVECs by significantly decreasing the levels of ET-1, vWF, and ICAM-1 and increasing the level of NO and the expression of eNOS. Additionally, we found that miR-149-5p can improve cell injury and reduce apoptosis by restoring the ameliorated high glucose-induced expression of ERS markers. Conclusion: TNF-α and miR-149-5p were differentially expressed in T2DM vascular endothelial injury. The over-expression of miR-149-5p ameliorates the high glucose-induced injury in the HUVECs by regulating the expression of TNF-α and ERS markers.

17 October 2018 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
RCRuixue Chen
Ruixue Chen
YXYa Xiao
Ya Xiao
MCMinghao Chen
Minghao Chen
JHJingyi He
Jingyi He
MHMengtian Huang
Mengtian Huang
LCLiguo Chen
Liguo Chen
Huoxue Huayu therapy (HXHY) has been widely used to treat cardiovascular diseases in traditional Chinese medicine (TCM), such as hypertension, and coronary heart disease (CHD). This study describes a meta-analysis of a series of prospective randomized, double-blind, placebo-controlled trials conducted to evaluate the effect of HXHY on patients with CHD after percutaneous coronary intervention (PCI).The Cochrane Library, PubMed, EMBASE, the China National Knowledge Infrastructure (CNKI), the Chinese Biomedical Literature database and the Wanfang database were searched up until June 2018. A series of randomized controlled clinical trials were included and the subjects were patients with CHD who had undergone PCI. The experimental group was treated with HXHY therapy, and the control group was treated with placebo; meanwhile, all the patients accepted conventional Western medicine. Review Manager 5.3 software was used for the statistical analysis. Ten trials were included in the final study. The overall risk of bias assessment was low. HXHY had a greater beneficial effect on reducing the in-stent restenosis (ISR) rate (RR=0.57, 95% CI [0.40, 0.80], P =0.001) and the degree of restenosis (MD=-8.89, 95% CI [-10.62, -7.17], P 0.05). Therefore, HXHY is an effective and safe therapy for CHD patients after PCI.

18 August 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LHLing He
Ling He
JYJing Yuan
Jing Yuan
QXQingyun Xu
Qingyun Xu
RCRuixue Chen
Ruixue Chen
LCLiguo Chen
Liguo Chen
MFMeixia Fang
Meixia Fang
In our previous study, we found significant differences in the mRNA and microRNA (miRNA) levels among hypertensive patients with different degrees of vascular endothelial cells damage. These differences were closely associated with endoplasmic reticulum stress (ERS)-related proteins. Moreover, compared to the control group, the expression of transcription factor activating factor 4 (ATF4) was also found to be significantly different in the hypertensive patients with different degrees of vascular endothelial cells damage groups. These results were confirmed using gene prediction software, which showed synergistic effects between ATF4 and miR-1283. ATF4 is a key molecule in ERS. Three ERS pathways exist:protein kinase RNA-like ER kinase (PERK), activating transcription factor 6 (ATF6) and inositol-requiring enzyme-1 (IRE-1)-induced apoptosis. The PERK pathway is the most important and also includes the phosphorylation of eukaryotic translation initiation factor 2α (eIF2α) and ATF4. In this report, we studied the regulatory effects of miR-1283 and ATF4 on the PERK-eIF2α-ATF4 signaling pathway using human umbilical vein endothelial cells (HUVECs) and mice. We verified the relationship between miR-1283 and ATF4 using a luciferase activity assay and observed the regulatory effects of miR-1283 and ATF4 on the PERK-eIF2α-ATF4 signaling pathway in vivo and in vitro. ATF4 is a target gene of miR-1283, which regulates the PERK-eIF2α-ATF4 signaling pathway by inhibiting ATF4, and it plays a critical role in inducing injury in HUVECs and mouse heart tissue.

1 January 2018 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
QLQiuer Liang
Qiuer Liang
YCYunfei Cai
Yunfei Cai
RCRuixue Chen
Ruixue Chen
WCWeihao Chen
Weihao Chen
LCLiguo Chen
Liguo Chen
YXYa Xiao
Ya Xiao
Objective. Naoxintong capsule (NXT) has been widely used to treat patients with cerebral infarction and carotid atherosclerosis. However, it is uncertain whether there is robust evidence on the effects of NXT for cerebral infarction and carotid atherosclerosis. A systematic review and meta‐analysis of randomized trials were performed to assess the efficacy of NXT in the treatment of cerebral infarction and carotid atherosclerosis. Methods. The Cochrane Library, EMBASE, the Medline database, the Wanfang database, the China National Knowledge Infrastructure, and the VIP database were searched up to January 2018 with no language restrictions. Study selection, data extraction, quality assessment, and data analyses were performed according to the Cochrane standards. Results. Eleven studies (N=1141) in total satisfied the inclusion criteria for the meta‐analysis. The results of meta‐analysis showed that compared with the conventional therapy alone, NXT combined with conventional therapy could significantly improve national institutes of health stroke scale (NIHSS) score (MD= ‐3.92, 95%CI: ‐4.31~‐3.52, P<0.00001), plaque area (MD= ‐0.16, 95%CI: ‐0.20~‐0.13, P<0.00001), carotid intima‐media thickness (IMT) (MD= ‐0.23, 95%CI: ‐0.26~‐0.20, P<0.00001), total cholesterol (TC) (MD= ‐0.16, 95%CI: ‐0.79~‐0.42, P<0.00001), triglyceride (TG) (MD= ‐0.69, 95%CI: ‐0.88~‐0.51, P<0.00001), high‐density lipoprotein cholesterol (HDL‐C) (MD= 0.23, 95%CI: 0.15~0.31, P<0.00001), and low‐density lipoprotein cholesterol (LDL‐C) (MD= ‐0.42, 95%CI: ‐0.58~‐0.25, P<0.00001). There were no reported adverse events in the studies. Conclusions. NXT is an effective and safe therapy option for patients with cerebral infarction and carotid atherosclerosis. However, due to the high clinical heterogeneity and small sample size of the included trials, further standardized preparation, large‐scale and rigorously designed trials are needed.

8 May 2015 in RSC Advances
Verified
Journal Article
Closed access
PDF file
RCRuixue Chen
Ruixue Chen
QWQingqing Wang
Qingqing Wang
YLYaru Li
Yaru Li
YGYue Gu
Yue Gu
LTLiu Tang
Liu Tang
ZZZhiquan Zhang
Zhiquan Zhang
Uniformly dispersed Ag/AgCl nanocubes (AgNC) were successfully obtained on reduced graphene oxide (rGO) through the simultaneous reduction of Ag+and graphene oxide (GO) by chitosan in the presence of a little HCl.

1 January 2020 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YXYa Xiao
Ya Xiao
WCWeihao Chen
Weihao Chen
RCRuixue Chen
Ruixue Chen
ALAnling Luo
Anling Luo
DCDayi Chen
Dayi Chen
WTWei Tan
Wei Tan
Objective. Gestational diabetes mellitus (GDM) is a pathological condition, affecting an increasing number of pregnant women worldwide. Safe and effective treatment for GDM is very important for the public health. In this study, we utilized a high‐fat diet‐induced GDM model to evaluate the effects of LBP on GDM and examined the changes of exosomal microRNA expression profiling to decipher the potential underlying mechanism of LBP. Methods. Female C57BL/6J mice were fed a control diet, HFD, or 150 mg/kg LBP‐supplemented HFD for 6 weeks before conception and throughout gestation. Oral glucose tolerance test and plasma lipid levels were determined, and liver histopathology was assessed. Sequencing was used to define the microRNA expression profiling of plasma exosomes in the three groups of mice, and protein expression levels of the candidate target genes were analyzed. Results. LBP significantly relieved glucose intolerance, abnormal plasma lipid levels, and pathomorphological changes of liver histopathology in HFD‐induced GDM mice. Moreover, we found that this effect of LBP was mediated by downregulation of the increase of 6 miRNAs (miR‐93‐3p, miR‐188‐5p, miR‐466k, miR‐1188‐5p, miR‐7001‐3p, and miR‐7115‐5p) and reversing the increase of the protein expression of CPT1A, which is the target gene of miR‐188‐5p. Conclusions. Our findings provide novel insights into the biological activities of LBP in the treatment of GDM.